EP0725015A1 - Emballage pour comprimés contenus dans un blister - Google Patents

Emballage pour comprimés contenus dans un blister Download PDF

Info

Publication number
EP0725015A1
EP0725015A1 EP96100893A EP96100893A EP0725015A1 EP 0725015 A1 EP0725015 A1 EP 0725015A1 EP 96100893 A EP96100893 A EP 96100893A EP 96100893 A EP96100893 A EP 96100893A EP 0725015 A1 EP0725015 A1 EP 0725015A1
Authority
EP
European Patent Office
Prior art keywords
blister
packaging
section
blister section
base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96100893A
Other languages
German (de)
English (en)
Inventor
Cojo Chinbuah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomedica Arzneimittel & Co KG GmbH
Original Assignee
Biomedica Arzneimittel & Co KG GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomedica Arzneimittel & Co KG GmbH filed Critical Biomedica Arzneimittel & Co KG GmbH
Publication of EP0725015A1 publication Critical patent/EP0725015A1/fr
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/04—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, spherical or like small articles, e.g. tablets or pills
    • B65D83/0445—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments
    • B65D83/0463—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments formed in a band or a blisterweb, inserted in a dispensing device or container

Definitions

  • the invention relates to a packaging of tablets or the like accommodated in a blister section according to the preamble of claim 1.
  • a blister strip can e.g. B. 1 to 20 or more tablets, coated tablets or capsules.
  • the actual packaging can contain 1 to 10 or more of the blister strips mentioned.
  • tablets hereinafter includes any type of solid drug, such as. B. also capsules, coated tablets, pellets and others.
  • tablets in the aforementioned sense can also contain food, nutritional supplements and tonics, vitamins, minerals, personal care products, etc.
  • pharmacies also require a package insert or a "leaflet” prescribed by the German Medicines Act, which contains information and instructions on the use and the profile of the drug in question in terms of consumer protection.
  • Used blister strips require special disposal because they often contain heavy metals and / or chlorine-containing plastics. However, since there is no special waste regulation for used blister strips, there is a considerable environmental impact from used drug blister strips.
  • the package insert also accommodates in the package, so that the user often takes this package insert out of the package and often throws it away when a blister strip is first removed. The consumer misses the information contained in the package insert for the time until the medication is used up. This can also result in a health risk for the consumer.
  • the Medicinal Products Act prescribes that the package insert must be of a certain size, design and legibility.
  • the medicinal product manufacturer is obliged to ensure that the package leaflet can be kept intact in the packaging and is visible inside the packaging whenever the package is opened.
  • a blister pack is known in which a blister strip is glued to a folding pack in such a way that the individual tablets of the blister strip overlap with cutouts of the folding pack and thus the Allow tablets to be removed while the blister strip remains attached to the folding pack.
  • This packaging is a blister packaging for tablets exclusively for the clinical testing of drugs, e.g. B. in clinics and hospitals.
  • the packaging is only intended to help the user to differentiate the medicament (verum) actually to be tested from the apparent tablet, the so-called "placebo".
  • placebo As described there, it is a "blister card” as such, on which an instruction (“instructions") - not to be confused with a "package insert” - is printed.
  • the blister card described in GB-OS-2 266 880 is not suitable for placing medicinal products on the market under pharmaceutical law.
  • the invention has for its object to provide a package for receiving tablets in a blister section, which is environmentally friendly, enables improved handling, ensures safe storage of tablets and package insert and is inexpensive.
  • a generic packaging is essentially characterized in that the blister section is inserted into a one-piece packaging blank, which in the folded state, the die Includes tablets containing side of the blister section and at the same time contains a receiving space for a package insert.
  • the invention ensures that the entire packaging is formed as a single piece, a part of which receives the blister section, which is usually inseparable from the rest of the packaging blank.
  • the fact that the tablets are inside the folded packaging means that they cannot be accidentally pressed out of the packaging or damaged. This also ensures "child safety”.
  • the blister section is preferably formed as part of a folded-out blank from rectangular carrier surfaces that can be closed at the open end by an adhesive strip. This ensures easy opening and reclosing of the packaging. It is not necessary to push a blister section into or out of separate packaging. This saves packaging cutting, the packaging remains secure and handling is significantly improved.
  • the special design of the packaging also allows the package insert to be inserted into a pocket of the package, where it is always available and the information in the package insert can be read at any time if required.
  • the empty blister strip can be removed and disposed of.
  • the user can insert new blister strips into the receiving pocket of the packaging according to the invention from a storage container which contains several blister strips of the same medicament.
  • the packaging according to the invention which generally carries a 10-pack blister strip, can be offered in combination with a large pack which contains larger quantities of the same medication in 10-pack blister strips.
  • the blister strips are then dimensioned such that they fit seamlessly into the above-mentioned receiving pocket of the packaging according to the invention.
  • the packaging according to the invention can also be used as a reusable bag for holding Serve blister strips. The user therefore always has smaller and smaller amounts of his medication at hand.
  • the packaging according to the invention can also be designed in such a way that the blister section is designed as an extension of a side wall of the packaging, the blister section being able to be inserted into the interior of the packaging by folding, so that packaging results in the folded state in which the blister section is enclosed on both sides by outer walls.
  • a packaging corresponds entirely to a conventional packaging in which blister strips are loosely accommodated.
  • the blister section can be part of the packaging blank, so that there is no need to slide a loose blister section out or in.
  • the packaging according to the invention it is also possible with the packaging according to the invention to use a plurality of blister sections which, however, are connected to one another and form part of the overall packaging blank. If there are more than two blister sections, these are folded, for example, in a zigzag fashion. It can be provided that the fold edges are perforated between individual blister sections in order to be able to prematurely separate an empty blister section from the rest of the packaging blank.
  • the packaging blank contains cutouts through which the raised foil areas of already finished blister sections can be carried out, the blister sections being glued to the rest of the packaging blank, for example, or being held by a cover surface.
  • a packaging according to the invention generally has sufficient free space on the inside of the packaging in order to be able to hold further information there, which was previously usually printed on a package insert, so that the package insert can be reduced in size.
  • packaging addresses a common problem with expiration date handling. Since the blister strips of conventional packaging are often lost after being removed from the packaging, it has previously been necessary for the expiry date to be printed on both the blister strips and on the packaging. In the case of the packaging according to the invention, the expiry date cannot be printed on the packaging, since the printing on the blister strip is sufficient. For this reason, it is preferred that the blister strip in the present packaging is designed in such a way that the expiry date always appears when it is pushed into the blister bag as intended. This saves one work step in the manufacture of the packaging and at the same time ensures compliance with the drug regulations on the expiry date.
  • Fig. 1 shows a packaging in the simplest form.
  • the packaging consists of two rectangular halves, one half being formed by the front side 1 and the other half by the rear side 2.
  • the halves are connected to one another via the underside 7. At their open edges they can be releasably attached to one another by an adhesive strip, which also forms the tamper-evident seal.
  • a tablet 3 Inside the front 1 and back 2 there is a tablet 3, enclosed between the back 2 and a transparent film 15, which forms the top of the blister strip.
  • Environmentally friendly, transparent natural or plastic materials can be used for this.
  • Transparent, solid strips of honey, gelatin, protein, starch and paper come into consideration as natural substances.
  • Polyethylene, propylant, polypropylene (PP) and similar substances can be used as plastics.
  • the back of the blister strip can be formed by water-repellent, tearable material.
  • z. B. aluminum coated paper z. B. aluminum coated paper.
  • Fig. 2 shows a rectangular packaging in which the front and back sides are separated only by a crease line 5.
  • the remaining structure of the packaging corresponds to that of Fig. 1.
  • the closure can also be formed by an adhesive strip 4 in this case.
  • the rear side 2 can directly form the rear cover layer of the blister section which is applied to a carrier board 14.
  • a corresponding sectional view of the rear side 2 is shown in FIG. 3.
  • a transparent film 15 is applied to the cover layer 16, which also forms the outside, the tablet 3 being located between the transparent film 15 and the cover layer 16.
  • the transparent film 15 is covered on the upper side by the carrier layer 14 provided with cutouts, which is part of the packaging blank.
  • the cover layer 16 consists in particular of an aluminum-paper connection, which on the one hand provides a sterile seal for the tablet receiving space guaranteed, on the other hand, however, it can be broken open from the inside onto a tablet by sufficient pressure.
  • FIG. 4 shows a cutout view of a packaging as it is preferably used in the embodiments according to FIGS. 1 and 2.
  • the back layer 17 provided with openings, which is part of the packaging blank, forms the back of the packaging to which a blister section with the cover layer 16 and a transparent film 15 is applied.
  • the blister section can, but need not, also be accommodated in an additional carrier layer 14.
  • Fig. 5 shows a package in which the base is folded back inside the package so that there are two sub-bases 18, 19 inside the package, which are placed back to back. As a result, two blister sections with tablets 3 and 20 can be accommodated simultaneously.
  • the partial base areas 18 and 19 are arranged parallel to the side walls 1 and 2. This is brought about by the edge section designed as a carrier tab 21.
  • the blister sections are placed back to back.
  • end faces of the packaging can remain open in all of the aforementioned embodiments, it can also be provided that the end faces are closed by side and folding tabs 24 and 25, as shown in a plan view of a package cutout according to FIG. 7 are.
  • the partial base areas 18 and 19 of the one-piece packaging blank are provided with cutouts 23 and form the carrier layer 14 for receiving the blister sections, the transparent films of which protrude through the cutouts 23.
  • the packaging blank has two carrier surfaces 8 and 9 connected to one another on the edge, of which the surface 9 has a lateral arcuate cutout 6. Since the carrier surfaces are connected to one another only on the edge side, in particular on the long sides, a pocket for accommodating the package insert, in which the latter is loosely accommodated, results after the carrier surfaces 8 and 9 are folded.
  • FIG. 8 A similar design without side flaps is shown in FIG. 8. It is also shown there that the base area contains a cutout 10 in which the embossed expiry date of the blister section can be seen.
  • a cover surface 13 which has a rectangular window 12 in order to be able to receive the tablets and which is glued to the base on three sides in order to form a receiving pocket for the blister section in this way.
  • the tablets When the blister strip is inserted into the pocket thus formed, the tablets can be pushed out through the back of the blister and through the openings in the base. After removing the last tablet, the blister strip can be removed and replaced with a new one from a storage box so that the amount of waste can be reduced.
  • FIG. 9 shows a finished packaging according to FIG. 8 with 10 tablets in a blister section 28.
  • the package insert 27 In the pocket of the carrier surface 9 there is the package insert 27, which can be removed if required, but which, unlike a conventional box, can remain in the packaging without any disruptive influence.

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Packages (AREA)
EP96100893A 1995-02-04 1996-01-23 Emballage pour comprimés contenus dans un blister Withdrawn EP0725015A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19503730 1995-02-04
DE19503730 1995-02-04

Publications (1)

Publication Number Publication Date
EP0725015A1 true EP0725015A1 (fr) 1996-08-07

Family

ID=7753216

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96100893A Withdrawn EP0725015A1 (fr) 1995-02-04 1996-01-23 Emballage pour comprimés contenus dans un blister

Country Status (1)

Country Link
EP (1) EP0725015A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0940353A1 (fr) * 1998-03-04 1999-09-08 Westvaco Corporation Découpe en carton pour un emballage autonome et refermable

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340141A (en) * 1981-02-23 1982-07-20 E. I. Du Pont De Nemours And Company Unit dose drug control package
EP0189276A2 (fr) * 1985-01-21 1986-07-30 Manrex Limited Emballage pour la distribution de médicaments
EP0307352A1 (fr) * 1987-08-07 1989-03-15 Ciba-Geigy Ag Emballage pour médicaments
US5242055A (en) * 1992-11-27 1993-09-07 Udl Laboratories, Inc. Packaging system for medication
FR2716443A1 (fr) * 1994-02-19 1995-08-25 Automotive Prod France Emballage de présentation.

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340141A (en) * 1981-02-23 1982-07-20 E. I. Du Pont De Nemours And Company Unit dose drug control package
EP0189276A2 (fr) * 1985-01-21 1986-07-30 Manrex Limited Emballage pour la distribution de médicaments
EP0307352A1 (fr) * 1987-08-07 1989-03-15 Ciba-Geigy Ag Emballage pour médicaments
US5242055A (en) * 1992-11-27 1993-09-07 Udl Laboratories, Inc. Packaging system for medication
FR2716443A1 (fr) * 1994-02-19 1995-08-25 Automotive Prod France Emballage de présentation.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0940353A1 (fr) * 1998-03-04 1999-09-08 Westvaco Corporation Découpe en carton pour un emballage autonome et refermable

Similar Documents

Publication Publication Date Title
DE69422683T2 (de) Verpackung für Kontaktlinsen
DE60102699T2 (de) Einzeldosisblisterverpackung mit schlüssellochöffnung
EP0718208B1 (fr) Emballage de type blister
EP1947027B1 (fr) Habillage transparent et procédé de stockage temporaire de produits
DE4429503C2 (de) Packung, insbesondere Arzneimittelpackung
DE2501640C3 (de) Packung zum Sichtbarmachen von verpackten Einzelerzeugnissen
DE2920162A1 (de) Blisterverpackung
DE3905851A1 (de) Arzneimittelpackung
EP0922651B1 (fr) Emballage refermable
EP0710206B1 (fr) Emballage de produits sous forme de morceaux
DE69400623T2 (de) Faltschachtel mit wiederverschliessbarer Öffnung
EP1481913A1 (fr) Emballage inviolable pour les enfants
DE4319609C1 (de) Spender für feste Arzneimittel
DE69328718T2 (de) Verbesserte blisterpackungen
EP0307352B1 (fr) Emballage pour médicaments
EP1108413B1 (fr) Utilisation d'un emballage du type "blister"
EP0725015A1 (fr) Emballage pour comprimés contenus dans un blister
CH537319A (de) Klappverpackung für Tabletten oder Pillen
EP1056657A1 (fr) Procede de production d'un emballage pour medicaments
DE29921100U1 (de) Blisterpackung
EP4000586A1 (fr) Récipient pour médicaments, ensemble permettant de former un récipient pour médicaments et procédé de fourniture d'un récipient pour médicaments
EP3924267B1 (fr) Emballage doté d'une sécurité enfant
DE202019102748U1 (de) Medikamentendispenser aus Zellstoff
DE29520904U1 (de) Verpackung zur Aufnahme von in einem Blisterabschnitt aufgenommenen Tabletten
DE7225796U (de) Musterpackung für Arzneimittel

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI NL PT SE

RBV Designated contracting states (corrected)

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI NL PT SE

17P Request for examination filed

Effective date: 19970207

17Q First examination report despatched

Effective date: 19971030

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19980511